Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMC Cancer|June 3, 2011
Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patientsPatricia de Cremoux, Fabien Valet, David Gentien, et al.
Breast Cancer Research and Treatment|December 16, 2014
HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenograftsPatricia de Cremoux, Mathieu Dalvai, Olivia N'Doye, et al.
Cancer Research|January 17, 2009
High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumorsElodie Manié, Anne Vincent-Salomon, Jacqueline Lehmann-Che, et al.
Plos One|May 11, 2010
Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinomaJérôme Verine, Jacqueline Lehmann-Che, Hany Soliman, et al.
Plos Medicine|March 29, 2007
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimenPhilippe Bertheau, Elisabeth Turpin, David S Rickman, et al.
Plos One|September 14, 2023
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study)Karen Leroy, Clarisse Audigier Valette, Jérôme Alexandre, et al.
Cancers|September 22, 2020
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NACLuca Campedel, Paul Blanc-Durand, Asker Bin Asker, et al.
European Urology Focus|July 30, 2017
Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic ReviewPierre-Jean Lamy, Yves Allory, Anne-Sophie Gauchez, et al.
Breast Cancer Research : BCR|May 14, 2013
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15Jacqueline Lehmann-Che, Anne-Sophie Hamy, Raphaël Porcher, et al.
Cancers|March 10, 2022
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant ChemotherapySylvie Giacchetti, Lilith Faucheux, Charlotte Gardair, et al.
Pageof 8